1. Home
  2. KLXE vs VERU Comparison

KLXE vs VERU Comparison

Compare KLXE & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLX Energy Services Holdings Inc.

KLXE

KLX Energy Services Holdings Inc.

HOLD

Current Price

$2.12

Market Cap

51.1M

Sector

Energy

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.25

Market Cap

48.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLXE
VERU
Founded
2018
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.1M
48.2M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
KLXE
VERU
Price
$2.12
$2.25
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$22.50
AVG Volume (30 Days)
179.4K
261.5K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$636,600,000.00
$16,296,958.00
Revenue This Year
$3.89
N/A
Revenue Next Year
$4.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.49
$0.36
52 Week High
$4.50
$7.33

Technical Indicators

Market Signals
Indicator
KLXE
VERU
Relative Strength Index (RSI) 40.85 37.05
Support Level $2.04 $2.11
Resistance Level $2.57 $2.67
Average True Range (ATR) 0.18 0.14
MACD 0.00 -0.02
Stochastic Oscillator 17.74 9.09

Price Performance

Historical Comparison
KLXE
VERU

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a growth-oriented provider of diversified oilfield services to onshore oil and natural gas exploration and production (E&P) companies operating in both conventional and unconventional plays in all of the active basins throughout the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Southwest region.

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Share on Social Networks: